Legal Representation
Attorney
Jennifer Insley-Pruitt
USPTO Deadlines
Next Deadline
105 days remaining
NOA E-Mailed - SOU Required
Due Date
April 09, 2026
Extension Available
Until October 09, 2026
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 9, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Sep 29, 2025 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Sep 30, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 22, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Sep 22, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Sep 22, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Sep 22, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Sep 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 18, 2025 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Sep 18, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 6, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 18, 2025 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Apr 7, 2025 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Sep 18, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Apr 7, 2025 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Apr 7, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 4, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 4, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 4, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 9, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 27, 2024 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Feb 28, 2024 | NEWN | I | NEW NOA TO ISSUE | Loading... |
| Feb 28, 2024 | IUCN | S | NOTICE OF ALLOWANCE CANCELLED | Loading... |
| Feb 23, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 23, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Feb 23, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 13, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 4, 2024 | ETOP | T | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | Loading... |
| Jul 24, 2023 | ETOF | T | EXTENSION OF TIME TO OPPOSE RECEIVED | Loading... |
| Jun 27, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 27, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 7, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 18, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 17, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 27, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 27, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 27, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 27, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 13, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 12, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the prevention of autoimmune,
inflammatory, gastrointestinal disease; Pharmaceutical preparations
for the prevention and treatment of oncologic, metabolic, rheumatic,
dermatological, endocrine, ophthalmologic, neurologic,
cardiovascular, musculoskeletal, viral, and fungal disease; vaccines
for human and veterinary use; adjuvants for use with vaccines
Classification
International Classes
005